{"_links": {"parentPackage": {"href": "/mdr/ct/packages/ddfct-2022-09-30", "title": "DDF Controlled Terminology Package 51 Effective 2022-09-30", "type": "Terminology"}, "rootItem": {"href": "/mdr/root/ct/ddfct/codelists/C188726", "title": "Version-agnostic anchor resource for codelist C188726", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/ddfct-2022-09-30/codelists/C188726", "title": "CDISC DDF Endpoint Level Value Set Terminology", "type": "Code List"}}, "conceptId": "C188726", "definition": "The terminology relevant to the endpoint level.", "name": "Endpoint Level Value Set Terminology", "preferredTerm": "CDISC DDF Endpoint Level Value Set Terminology", "submissionValue": "Endpoint Level Value Set Terminology", "synonyms": ["Endpoint Level Value Set Terminology"], "terms": [{"conceptId": "C170559", "definition": "Endpoint(s) that may include clinically important events that are expected to occur too infrequently to show a treatment effect or endpoints that for other reasons are thought to be less likely to show an effect but are included to explore new hypotheses. (After FDA-NIH Protocol Template)", "preferredTerm": "Exploratory Endpoint", "submissionValue": "Exploratory Endpoint"}, {"conceptId": "C94496", "definition": "Endpoint(s) of greatest importance that is the basis for concluding whether the study met its objective(s) and provides a clinically relevant, valid, and reliable measure of the primary objective(s). (After FDA-NIH Protocol Template)", "preferredTerm": "Primary Endpoint", "submissionValue": "Primary Endpoint"}, {"conceptId": "C139173", "definition": "Endpoint(s) that may provide supportive information about the effect of the study intervention(s) on the primary endpoint or demonstrate additional effects on the disease or condition. (After FDA-NIH Protocol Template)", "preferredTerm": "Secondary Endpoint", "submissionValue": "Secondary Endpoint"}]}